- Home
- MXCT vs CVRX Comparison
MXCT vs CVRX Comparison
Compare MXCT & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MXCT
- CVRX
- Stock Information
- Founded
- MXCT 1999
- CVRX 2000
- Country
- MXCT United States
- CVRX United States
- Employees
- MXCT N/A
- CVRX N/A
- Industry
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MXCT Health Care
- CVRX Health Care
- Exchange
- MXCT Nasdaq
- CVRX Nasdaq
- Market Cap
- MXCT 361.8M
- CVRX 419.8M
- IPO Year
- MXCT 2021
- CVRX 2021
- Fundamental
- Price
- MXCT $2.71
- CVRX $12.53
- Analyst Decision
- MXCT Strong Buy
- CVRX Strong Buy
- Analyst Count
- MXCT 2
- CVRX 7
- Target Price
- MXCT $10.00
- CVRX $17.83
- AVG Volume (30 Days)
- MXCT 701.5K
- CVRX 210.8K
- Earning Date
- MXCT 03-11-2025
- CVRX 04-29-2025
- Dividend Yield
- MXCT N/A
- CVRX N/A
- EPS Growth
- MXCT N/A
- CVRX N/A
- EPS
- MXCT N/A
- CVRX N/A
- Revenue
- MXCT $38,627,000.00
- CVRX $51,292,000.00
- Revenue This Year
- MXCT $20.01
- CVRX $27.21
- Revenue Next Year
- MXCT $26.64
- CVRX $25.87
- P/E Ratio
- MXCT N/A
- CVRX N/A
- Revenue Growth
- MXCT N/A
- CVRX 30.53
- 52 Week Low
- MXCT $2.62
- CVRX $6.40
- 52 Week High
- MXCT $5.26
- CVRX $19.24
- Technical
- Relative Strength Index (RSI)
- MXCT 27.30
- CVRX 48.53
- Support Level
- MXCT $2.62
- CVRX $11.95
- Resistance Level
- MXCT $3.17
- CVRX $12.94
- Average True Range (ATR)
- MXCT 0.17
- CVRX 0.57
- MACD
- MXCT -0.02
- CVRX 0.16
- Stochastic Oscillator
- MXCT 11.27
- CVRX 66.39
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.